(Q44067854)

29 November 2017

title

Anaemia: The safety and efficacy of peginesatide in patients with CKD. (English)

1 reference

29 November 2017

1

Kai-Uwe Eckardt

1 reference

29 November 2017

language of work or name

English

0 references

publication date

12 March 2013

1 reference

Nature Reviews Nephrology

29 November 2017

published in

1 reference

29 November 2017

volume

9

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

192-193

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.42

29 November 2017

exact match

0 references

cites work

Small peptides as potent mimetics of the protein hormone erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

Peginesatide in patients with anemia undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

Correction of anemia with epoetin alfa in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.42

31 March 2020

Identifiers

DOI

10.1038/NRNEPH.2013.42

1 reference

29 November 2017

1 reference